Tissue Sectioning Market Growth & Opportunity 2021 to 2028

The tissue sectioning market is projected to reach US$ 904.86 million by 2028 from US$ 580.29 million in 2021; it is expected to grow at a CAGR of 6.6% from 2021 to 2028.

Tissue sectioning is a procedure that involves cutting tissues into thin sections so that they can be placed on a slide and then mounted under a microscope for study. It is used to examine the tissue to detect any abnormalities or disease conditions. It is employed in histology laboratories, science laboratories, and other settings. Tissue processing is carried out after tissue has been examined between tissue embedding and fixation.

The report offers insights and in-depth analysis of the tissue sectioning market, emphasizing various parameters such as market trends, technological advancements, market dynamics, and competitive landscape analysis of leading market players worldwide. It also includes the impact of the COVID-19 pandemic on the market across all the regions. The pandemic has disrupted the socioeconomic conditions of various countries across the world. Presently, the US is the world's worst-affected country due to the COVID-19 outbreak with the highest number of confirmed cases and deaths, as per the recent WHO statistics. The high number of COVID-19 positive cases has negatively impacted the global economies. There has been a decline in overall business activities and the growth of various industries operating worldwide.

Customize This Report To Suit Your Requirement

You will get customization on any report - free of charge - including parts of this report, or country-level analysis, Excel Data pack, as well as avail great offers and discounts for start-ups & universities

Get FREE CUSTOMIZATION

Tissue Sectioning Market: Strategic Insights

• Get Top Key Market Trends of this report.
  This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.

Free Sample PDF

There have been various factors, including increased incidence of COVID-19 positive patients, growth in research, rise in production of vaccines, outcome study of administered vaccines, and many other factors. For instance, research was conducted by the College of American Pathologists to report demographic and radiographic features in the lungs of patients infected and deceased with fatal COVID-19. All autopsies were performed at the College of American Pathologists. The study revealed that patients infected with COVID-19 not only have diffuse alveolar damage but also commonly have acute bronchopneumonia and aspiration pneumonia. The cases majorly led to the demand for diagnostic tests in the countries like the US, Canada, and Mexico. Thus, the tissue sectioning market in North America is positively impacted by COVID-19.

Based on region, the tissue sectioning market is segmented into North America, Europe, Asia Pacific, the Middle East & Africa, and South and Central America.

 

Market Insights

Rising Adoption of Personalized Medicine  to Drive Tissue Sectioning Market

Personalized or precision medicine has become the hallmark of treatment for a number of severe diseases and has expanded to other fields with its application. It is a constantly emerging approach to customizing therapies based on patients' genetic accumulation. These technological advancements have led to tissue sectioning approaches that achieve better results with the available resources in less time. For the prevention and efficient treatment of a disease, personalized medicines are mandatory tools, especially in oncology and nephrology cases. The rapidly increasing cancer cases are indirectly contributing to the growth of the tissue sectioning market.

For instance, as per the WHO, cancer is the leading cause of death worldwide, accounting for nearly 10 million demises in 2020. Lung cancer, liver cancer, blood cancer, and breast cancer are the most common cancer types. Between 30% and 50% of cancers can currently be prevented through early cancer diagnosis and appropriate treatment and care of patients. Many cancers have a high chance of being cured if diagnosed early and treated appropriately, stated the WHO. The increasing use of personalized medicine has prompted a rise in demand for human tissue use to foster innovative tests.

Product-Based Insights

Based on product, the tissue sectioning market is categorized into instruments, accessories & consumables, and services. The instruments segment accounted for the largest share of the market. The instrument segment is subsegmented into rotary microtome, sliding microtome, ultramicrotome, cryostat, and others.  

Technology-Based Insights

Based on technology, the tissue sectioning market is segmented into automatic, semiautomatic, and manual. The automatic technology segment would hold the largest share of the market in 2021, and the same segment is estimated to register the highest CAGR of 7.0% in the market during the forecast period.

Application-Based Insights

Based on application, the tissue sectioning market is segmented into diagnosis and research. In 2021, the diagnosis segment would hold the largest share of the market. Moreover, the research segment is also expected to witness growth at the fastest CAGR of 7.2% from 2021 to 2028.

End User-Based Insights

Based on end user, the tissue sectioning market is segmented into hospitals, research institutions, and others. The research institutions segment would hold the largest share of the market in 2021, and the same segment is anticipated to register the highest CAGR of 10.9% of the market during the forecast period.

The tissue sectioning market players adopt organic strategies such as product launch and expansion to expand their footprint and product portfolio worldwide and meet the growing demand.

Tissue Sectioning Market Regional Insights

The regional trends and factors influencing the Tissue Sectioning Market throughout the forecast period have been thoroughly explained by the analysts at Insight Partners. This section also discusses Tissue Sectioning Market segments and geography across North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America.

Tissue Sectioning Market Report Scope

Tissue Sectioning Market Players Density: Understanding Its Impact on Business Dynamics

The Tissue Sectioning Market market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.

Market players density refers to the distribution of firms or companies operating within a particular market or industry. It indicates how many competitors (market players) are present in a given market space relative to its size or total market value.

Major Companies operating in the Tissue Sectioning Market are:

1. Thermo Fisher Scientific
2. Leica Biosystems Nussloch GmbH
3. LLS ROWIAK LaserLabSolutions GmbH
4. Sakura Finetek Europe B.V
5. Diapath S.p.A.

Disclaimer: The companies listed above are not ranked in any particular order.

 

By Product

• Instruments
  • Rotary Microtome
  • Ultramicrotome
  • Cryostat
  • Sliding Microtome
  • Others
• Accessories and Consumables
• Services

By Technology

• Automatic
• Semi-Automatic
• Manual

By Application

• Diagnosis
• Research

By End-User

• Hospitals
• Clinics
• Diagnostic Laboratories
• Digital Path Labs
• Others

By Geography

• North America
  • US
  • Canada
  • Mexico
• Europe
  • France
  • Germany
  • Italy
  • UK
  • Spain
• Asia Pacific (APAC)
  • China
  • India
  • South Korea
  • Japan
  • Australia
• Middle East & Africa (MEA)
  • South Africa
  • Saudi Arabia
  • Israel
• South and Central America (SCAM)
  • Brazil

Company Profiles

• Thermo Fisher Scientific
• Leica Biosystems Nussloch GmbH
• LLS ROWIAK LaserLabSolutions GmbH
• Sakura Finetek Europe B.V
• Diapath S.p.A.
• Histo-line Laboratories
• Medite Medical GmbH
• SLEE medical GmbH
• Abcam plc
• Amas Scientific Pty Ltd